Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 753

1.

Real-world healthcare resource utilization in patients with indolent non-Hodgkin lymphoma: differences between patients treated with first-line ibrutinib or bendamustine + rituximab.

Irwin DE, Wilson K, Hoehn G, Min S, Szabo E.

Curr Med Res Opin. 2020 Jan 20:1-6. doi: 10.1080/03007995.2020.1713074. [Epub ahead of print]

PMID:
31910684
2.

Attenuated total reflection fourier transform infrared spectroscopy based methods for identification of chromatography media formulations used in downstream processes.

Szabó É, Baranyai LZ, Sütő Z, Salgó A, Gergely S.

J Pharm Biomed Anal. 2019 Dec 19;180:113060. doi: 10.1016/j.jpba.2019.113060. [Epub ahead of print]

PMID:
31896522
3.

Scale-up of electrospinning technology: Applications in the pharmaceutical industry.

Vass P, Szabó E, Domokos A, Hirsch E, Galata D, Farkas B, Démuth B, Andersen SK, Vigh T, Verreck G, Marosi G, Nagy ZK.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Dec 20:e1611. doi: 10.1002/wnan.1611. [Epub ahead of print] Review.

PMID:
31863572
4.

Cancer Prevention in Primary Care: Perception of Importance, Recognition of Risk Factors and Prescribing Behaviors.

Samimi G, Heckman-Stoddard BM, Holmberg C, Tennant B, Sheppard BB, Coa KI, Kay SS, Ford LG, Szabo E, Minasian LM.

Am J Med. 2019 Dec 17. pii: S0002-9343(19)31095-2. doi: 10.1016/j.amjmed.2019.11.017. [Epub ahead of print]

PMID:
31862335
5.

A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index.

Zell JA, McLaren CE, Morgan TR, Lawson MJ, Rezk S, Albers CG, Chen WP, Carmichael JC, Chung J, Richmond E, Rodriguez LM, Szabo E, Ford LG, Pollak MN, Meyskens FL.

Cancer Prev Res (Phila). 2019 Dec 9. pii: canprevres.0262.2018. doi: 10.1158/1940-6207.CAPR-18-0262. [Epub ahead of print]

PMID:
31818851
6.

Continuous Formulation Approaches of Amorphous Solid Dispersions: Significance of Powder Flow Properties and Feeding Performance.

Szabó E, Démuth B, Galata DL, Vass P, Hirsch E, Csontos I, Marosi G, Nagy ZK.

Pharmaceutics. 2019 Dec 5;11(12). pii: E654. doi: 10.3390/pharmaceutics11120654. Review.

7.

Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007-2015: A registry-based cohort study.

Jans A, Näslund I, Ottosson J, Szabo E, Näslund E, Stenberg E.

PLoS Med. 2019 Nov 20;16(11):e1002985. doi: 10.1371/journal.pmed.1002985. eCollection 2019 Nov.

8.

[Changes of lactate levels in diabetic ketoacidosis and in newly diagnosed type 1 diabetes mellitus].

Jenei K, Szatmári I, Szabó E, Mariam A, Luczay A, Zsidegh P, Tóth-Heyn P.

Orv Hetil. 2019 Nov;160(45):1784-1790. doi: 10.1556/650.2019.31533. Hungarian.

PMID:
31680540
9.

Targeting mTOR in Head and Neck Cancer-Response.

Gutkind JS, Day TA, Lippman SM, Szabo E.

Clin Cancer Res. 2019 Nov 1;25(21):6555. doi: 10.1158/1078-0432.CCR-19-2002. No abstract available.

PMID:
31676588
10.

Predictive factors of complications in revisional gastric bypass surgery: results from the Scandinavian Obesity Surgery Registry.

Axer S, Szabo E, Agerskov S, Näslund I.

Surg Obes Relat Dis. 2019 Dec;15(12):2094-2100. doi: 10.1016/j.soard.2019.09.071. Epub 2019 Sep 24.

PMID:
31640905
11.

Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma.

Rajan A, Heery CR, Thomas A, Mammen AL, Perry S, O'Sullivan Coyne G, Guha U, Berman A, Szabo E, Madan RA, Ballester LY, Pittaluga S, Donahue RN, Tsai YT, Lepone LM, Chin K, Ginty F, Sood A, Hewitt SM, Schlom J, Hassan R, Gulley JL.

J Immunother Cancer. 2019 Oct 21;7(1):269. doi: 10.1186/s40425-019-0723-9.

12.

Continuous drying of a protein-type drug using scaled-up fiber formation with HP-β-CD matrix resulting in a directly compressible powder for tableting.

Vass P, Nagy ZK, Kóczián R, Fehér C, Démuth B, Szabó E, Andersen SK, Vigh T, Verreck G, Csontos I, Marosi G, Hirsch E.

Eur J Pharm Sci. 2020 Jan 1;141:105089. doi: 10.1016/j.ejps.2019.105089. Epub 2019 Oct 15.

PMID:
31626967
13.

Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models.

von Achenbach C, Weller M, Kaulich K, Gramatzki D, Zacher A, Fabbro D, Reifenberger G, Szabó E.

J Neurochem. 2019 Oct 16. doi: 10.1111/jnc.14899. [Epub ahead of print]

PMID:
31618458
14.

Increased activation of the pregenual anterior cingulate cortex to citalopram challenge in migraine: an fMRI study.

Edes AE, McKie S, Szabo E, Kokonyei G, Pap D, Zsombok T, Magyar M, Csepany E, Hullam G, Szabo AG, Kozak LR, Bagdy G, Juhasz G.

BMC Neurol. 2019 Oct 15;19(1):237. doi: 10.1186/s12883-019-1478-0.

15.

Discovery and development of extreme selective inhibitors of the ITD and D835Y mutant FLT3 kinases.

Baska F, Sipos A, Őrfi Z, Nemes Z, Dobos J, Szántai-Kis C, Szabó E, Szénási G, Dézsi L, Hamar P, Cserepes MT, Tóvári J, Garamvölgyi R, Krekó M, Őrfi L.

Eur J Med Chem. 2019 Dec 15;184:111710. doi: 10.1016/j.ejmech.2019.111710. Epub 2019 Oct 5.

PMID:
31614258
16.

Spatiotemporal brain activation pattern following acute citalopram challenge is dose dependent and associated with neuroticism: A human phMRI study.

Edes AE, McKie S, Szabo E, Kokonyei G, Pap D, Zsombok T, Hullam G, Gonda X, Kozak LR, McFarquhar M, Anderson IM, Deakin JFW, Bagdy G, Juhasz G.

Neuropharmacology. 2019 Oct 5:107807. doi: 10.1016/j.neuropharm.2019.107807. [Epub ahead of print]

PMID:
31593709
17.

[Psychometric properties of the Inventory of Callous-Unemotional Traits in a high-risk sample of adolescent boy].

Szabó E, Kökönyei G.

Psychiatr Hung. 2019;34(3):266-279. Hungarian.

PMID:
31570658
18.

Altered Cell Surface N-Glycosylation of Resting and Activated T Cells in Systemic Lupus Erythematosus.

Szabó E, Hornung Á, Monostori É, Bocskai M, Czibula Á, Kovács L.

Int J Mol Sci. 2019 Sep 10;20(18). pii: E4455. doi: 10.3390/ijms20184455.

19.

Ecological and cultural factors underlying the global distribution of prejudice.

Jackson JC, van Egmond M, Choi VK, Ember CR, Halberstadt J, Balanovic J, Basker IN, Boehnke K, Buki N, Fischer R, Fulop M, Fulmer A, Homan AC, van Kleef GA, Kreemers L, Schei V, Szabo E, Ward C, Gelfand MJ.

PLoS One. 2019 Sep 6;14(9):e0221953. doi: 10.1371/journal.pone.0221953. eCollection 2019.

20.

Spilanthol Inhibits Inflammatory Transcription Factors and iNOS Expression in Macrophages and Exerts Anti-inflammatory Effects in Dermatitis and Pancreatitis.

Bakondi E, Singh SB, Hajnády Z, Nagy-Pénzes M, Regdon Z, Kovács K, Hegedűs C, Madácsy T, Maléth J, Hegyi P, Demény MÁ, Nagy T, Kéki S, Szabó É, Virág L.

Int J Mol Sci. 2019 Sep 3;20(17). pii: E4308. doi: 10.3390/ijms20174308.

21.

A Convenient Synthetic Method to Improve Immunogenicity of Mycobacterium tuberculosis Related T-Cell Epitope Peptides.

Horváti K, Pályi B, Henczkó J, Balka G, Szabó E, Farkas V, Biri-Kovács B, Szeder B, Fodor K.

Vaccines (Basel). 2019 Aug 27;7(3). pii: E101. doi: 10.3390/vaccines7030101.

22.

Effect of Intermittent Versus Continuous Low-Dose Aspirin on Nasal Epithelium Gene Expression in Current Smokers: A Randomized, Double-Blinded Trial.

Garland LL, Guillen-Rodriguez J, Hsu CH, Yozwiak M, Zhang HH, Alberts DS, Davis LE, Szabo E, Merenstein C, Lel J, Zhang X, Liu H, Liu G, Spira AE, Beane JE, Wojtowicz M, Chow HS.

Cancer Prev Res (Phila). 2019 Nov;12(11):809-820. doi: 10.1158/1940-6207.CAPR-19-0036. Epub 2019 Aug 26.

PMID:
31451521
23.

Fast, Spectroscopy-Based Prediction of In Vitro Dissolution Profile of Extended Release Tablets Using Artificial Neural Networks.

Galata DL, Farkas A, Könyves Z, Mészáros LA, Szabó E, Csontos I, Pálos A, Marosi G, Nagy ZK, Nagy B.

Pharmaceutics. 2019 Aug 9;11(8). pii: E400. doi: 10.3390/pharmaceutics11080400.

24.

A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer.

Komiya T, Memmott RM, Blumenthal GM, Bernstein W, Ballas MS, De Chowdhury R, Chun G, Peer CJ, Figg WD, Liewehr DJ, Steinberg SM, Giaccone G, Szabo E, Kawabata S, Tsurutani J, Rajan A, Dennis PA.

Transl Lung Cancer Res. 2019 Jun;8(3):247-257. doi: 10.21037/tlcr.2019.04.19.

25.

TMEM203 is a binding partner and regulator of STING-mediated inflammatory signaling in macrophages.

Li Y, James SJ, Wyllie DH, Wynne C, Czibula A, Bukhari A, Pye K, Bte Mustafah SM, Fajka-Boja R, Szabo E, Angyal A, Hegedus Z, Kovacs L, Hill AVS, Jefferies CA, Wilson HL, Yongliang Z, Kiss-Toth E.

Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16479-16488. doi: 10.1073/pnas.1901090116. Epub 2019 Jul 25.

26.

Scaled-Up Production and Tableting of Grindable Electrospun Fibers Containing a Protein-Type Drug.

Vass P, Hirsch E, Kóczián R, Démuth B, Farkas A, Fehér C, Szabó E, Németh Á, Andersen SK, Vigh T, Verreck G, Csontos I, Marosi G, Nagy ZK.

Pharmaceutics. 2019 Jul 11;11(7). pii: E329. doi: 10.3390/pharmaceutics11070329.

27.

Underlying molecular alterations in human dihydrolipoamide dehydrogenase deficiency revealed by structural analyses of disease-causing enzyme variants.

Szabo E, Wilk P, Nagy B, Zambo Z, Bui D, Weichsel A, Arjunan P, Torocsik B, Hubert A, Furey W, Montfort WR, Jordan F, Weiss MS, Adam-Vizi V, Ambrus A.

Hum Mol Genet. 2019 Oct 15;28(20):3339-3354. doi: 10.1093/hmg/ddz177.

PMID:
31334547
28.

Feasibility of proton FLASH effect tested by zebrafish embryo irradiation.

Beyreuther E, Brand M, Hans S, Hideghéty K, Karsch L, Leßmann E, Schürer M, Szabó ER, Pawelke J.

Radiother Oncol. 2019 Oct;139:46-50. doi: 10.1016/j.radonc.2019.06.024. Epub 2019 Jun 29.

PMID:
31266652
29.

Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung Cancer.

Davis JS, Prophet E, Peng HL, Lee HY, Tidwell RSS, Lee JJ, Thomas A, Szabo E, Chang S.

JNCI Cancer Spectr. 2019 Jun;3(2):pkz010. doi: 10.1093/jncics/pkz010. Epub 2019 Apr 15.

30.

Association between migraine frequency and neural response to emotional faces: An fMRI study.

Szabó E, Galambos A, Kocsel N, Édes AE, Pap D, Zsombók T, Kozák LR, Bagdy G, Kökönyei G, Juhász G.

Neuroimage Clin. 2019;22:101790. doi: 10.1016/j.nicl.2019.101790. Epub 2019 Mar 26.

31.

Effects of Whole-Body Vibration Therapy on Distal Tibial Myotendinous Density and Volume: A Randomized Controlled Trial in Postmenopausal Women.

Boggild MK, Tomlinson G, Erlandson MC, Szabo E, Giangregorio LM, Craven BC, Slatkovska L, Alibhai SM, Cheung AM.

JBMR Plus. 2018 Dec 13;3(5):e10120. doi: 10.1002/jbm4.10120. eCollection 2019 May.

32.

A systematic review of structural and functional MRI studies on pain catastrophizing.

Galambos A, Szabó E, Nagy Z, Édes AE, Kocsel N, Juhász G, Kökönyei G.

J Pain Res. 2019 Apr 11;12:1155-1178. doi: 10.2147/JPR.S192246. eCollection 2019.

33.

11Boron Delivery Agents for Boron Proton-capture Enhanced Proton Therapy.

Hideghéty K, Brunner S, Cheesman A, Szabó ER, Polanek R, Margarone D, Tőkés T, Mogyorósi K.

Anticancer Res. 2019 May;39(5):2265-2276. doi: 10.21873/anticanres.13343. Review.

PMID:
31092418
34.

Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study.

Thomas A, Vilimas R, Trindade C, Erwin-Cohen R, Roper N, Xi L, Krishnasamy V, Levy E, Mammen A, Nichols S, Chen Y, Velcheti V, Yin F, Szabo E, Pommier Y, Steinberg SM, Trepel JB, Raffeld M, Young HA, Khan J, Hewitt S, Lee JM.

J Thorac Oncol. 2019 Aug;14(8):1447-1457. doi: 10.1016/j.jtho.2019.04.026. Epub 2019 May 4.

PMID:
31063862
35.

The association between perseverative cognition and resting heart rate variability: A focus on state ruminative thoughts.

Kocsel N, Köteles F, Szemenyei E, Szabó E, Galambos A, Kökönyei G.

Biol Psychol. 2019 Jul;145:124-133. doi: 10.1016/j.biopsycho.2019.04.004. Epub 2019 Apr 30.

PMID:
31051207
36.

Modelling of avoidance of food additives: a cross country study.

Szűcs V, Szabó E, Guerrero L, Tarcea M, Bánáti D.

Int J Food Sci Nutr. 2019 Dec;70(8):1020-1032. doi: 10.1080/09637486.2019.1597837. Epub 2019 Apr 16.

PMID:
30987483
37.

Combined Deterministic and Stochastic Processes Control Microbial Succession in Replicate Granular Biofilm Reactors.

Liébana R, Modin O, Persson F, Szabó E, Hermansson M, Wilén BM.

Environ Sci Technol. 2019 May 7;53(9):4912-4921. doi: 10.1021/acs.est.8b06669. Epub 2019 Apr 22.

PMID:
30969774
38.

A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol.

Zeng Y, Moscicki AB, Sahasrabuddhe VV, Garcia F, Woo H, Hsu CH, Szabo E, Dimond E, Vanzzini S, Mondragon A, Butler V, DeRose H, Chow HS.

BMC Cancer. 2019 Apr 1;19(1):290. doi: 10.1186/s12885-019-5444-4.

39.

Altered neural activity to monetary reward/loss processing in episodic migraine.

Kocsel N, Galambos A, Szabó E, Édes AE, Magyar M, Zsombók T, Pap D, Kozák LR, Bagdy G, Kökönyei G, Juhász G.

Sci Rep. 2019 Apr 1;9(1):5420. doi: 10.1038/s41598-019-41867-x.

40.

A novel tool for structure assignment of hydroxylated metabolites of (arylpiperazinylbutyl)oxindole derivatives based on relative HPLC retention times.

Szabó É, Koványi-Lax G, Szénási G, Dancsó A, Kiss L, Kormány R, Simig G, Németh G, Volk B.

J Pharm Biomed Anal. 2019 Jun 5;170:102-111. doi: 10.1016/j.jpba.2019.03.019. Epub 2019 Mar 11.

PMID:
30909055
41.

The impact of socioeconomic factors on the early postoperative complication rate after laparoscopic gastric bypass surgery: A register-based cohort study.

Stenberg E, Persson C, Näslund E, Ottosson J, Sundbom M, Szabo E, Näslund I.

Surg Obes Relat Dis. 2019 Apr;15(4):575-581. doi: 10.1016/j.soard.2019.01.025. Epub 2019 Jan 31.

PMID:
30826242
42.

Acceptability of Localized Cancer Risk Reduction Interventions Among Individuals at Average or High Risk for Cancer.

Samimi G, Heckman-Stoddard BM, Kay SS, Bloodgood B, Coa KI, Robinson JL, Tennant B, Ford LG, Szabo E, Minasian L.

Cancer Prev Res (Phila). 2019 Apr;12(4):271-282. doi: 10.1158/1940-6207.CAPR-18-0435. Epub 2019 Mar 1.

PMID:
30824471
43.

Continuous alternative to freeze drying: Manufacturing of cyclodextrin-based reconstitution powder from aqueous solution using scaled-up electrospinning.

Vass P, Démuth B, Farkas A, Hirsch E, Szabó E, Nagy B, Andersen SK, Vigh T, Verreck G, Csontos I, Marosi G, Nagy ZK.

J Control Release. 2019 Mar 28;298:120-127. doi: 10.1016/j.jconrel.2019.02.019. Epub 2019 Feb 16.

44.

Undergraduate lab series using the K562 human leukemia cell line: Model for cell growth, death, and differentiation in an advanced cell biology course.

Phelan SA, Szabo E.

Biochem Mol Biol Educ. 2019 May;47(3):263-271. doi: 10.1002/bmb.21222. Epub 2019 Feb 6.

PMID:
30725506
45.

Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.

Tigyi GJ, Johnson LR, Lee SC, Norman DD, Szabo E, Balogh A, Thompson K, Boler A, McCool WS.

J Lipid Res. 2019 Mar;60(3):464-474. doi: 10.1194/jlr.S091744. Epub 2019 Jan 28.

PMID:
30692142
46.

Comparing Techniques for Mesenteric Defects Closure in Laparoscopic Gastric Bypass Surgery-a Register-Based Cohort Study.

Stenberg E, Ottosson J, Szabo E, Näslund I.

Obes Surg. 2019 Apr;29(4):1229-1235. doi: 10.1007/s11695-018-03670-x.

PMID:
30675687
47.

Callous-unemotional traits and the attentional bias towards emotional stimuli: Testing the moderating role of emotional and behavioural problems among high-risk adolescents.

Szabó E, Halász J, Morgan A, Demetrovics Z, Kökönyei G.

Clin Child Psychol Psychiatry. 2020 Jan;25(1):156-173. doi: 10.1177/1359104518822690. Epub 2019 Jan 16.

PMID:
30648434
48.

A multivariate approach to predict the volumetric and gravimetric feeding behavior of a low feed rate feeder based on raw material properties.

Bostijn N, Dhondt J, Ryckaert A, Szabó E, Dhondt W, Van Snick B, Vanhoorne V, Vervaet C, De Beer T.

Int J Pharm. 2019 Feb 25;557:342-353. doi: 10.1016/j.ijpharm.2018.12.066. Epub 2018 Dec 29.

PMID:
30599227
49.

Redox Profiling Reveals Clear Differences between Molecular Patterns of Wound Fluids from Acute and Chronic Wounds.

Bodnár E, Bakondi E, Kovács K, Hegedűs C, Lakatos P, Robaszkiewicz A, Regdon Z, Virág L, Szabó É.

Oxid Med Cell Longev. 2018 Nov 18;2018:5286785. doi: 10.1155/2018/5286785. eCollection 2018.

50.

Profound, durable and MGMT-independent sensitivity of glioblastoma cells to cyclin-dependent kinase inhibition.

Le Rhun E, von Achenbach C, Lohmann B, Silginer M, Schneider H, Meetze K, Szabo E, Weller M.

Int J Cancer. 2019 Jul 1;145(1):242-253. doi: 10.1002/ijc.32069. Epub 2019 Jan 12.

PMID:
30549269

Supplemental Content

Support Center